Among these, POLE mutant endometrial cancer has the best prognosis, while P53 mutant endometrial cancer is considered to have the worst prognosis due to its higher malignancy, poor prognosis, and treatment complexity, which has attracted widespread attention [9]. Here, TP53 is linked to endometrial cancer.